[1]
|
Yu Y, Xu F, Peng H, et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas[J]. PNAS, 1999, 96: 214-219. doi: 10.1073/pnas.96.1.214 |
[2]
|
Yang H, Lu X, Qian J, et al. Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells[J]. Mol Med Rep, 2010, 3: 581. |
[3]
|
Yang H, Rao JN, Wang JY. Posttranscriptional regulation of intestinal epithelial tight junction barrier by RNA-binding proteins and microRNAs[J]. Tissue Barriers, 2014, 2: e28320. doi: 10.4161/tisb.28320 |
[4]
|
Liu L, Christodoulou-Vafeiadou E, Rao JN, et al. RNA-binding protein HuR promotes growth of small intestinal mucosa by activating the Wnt signaling pathway [J]. Mol Biol Cell, 2014, 25:3308-3318. doi: 10.1091/mbc.e14-03-0853 |
[5]
|
Blancoo FF, Jimbo M, Wulfkuhle J, et al. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells[J]. Oncogene, 2016, 35:2529-2541. doi: 10.1038/onc.2015.325 |
[6]
|
Jimbo M, Blanco FF, Huang YH, et al. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells[J].Oncotarget, 2015, 6: 27312-27331. doi: 10.18632/oncotarget.4743 |
[7]
|
Costanitino CL, Witkiewica AK, Kuwano Y, et al. HuR's role in gemcitabine efficacy in pancreatic cancer: HuRupregulates the expression of the gemcitabine metabolizing enzyme, deoxycytidinekinase[J].Cancer Res, 2009, 69: 4567-4572. doi: 10.1158/0008-5472.CAN-09-0371 |
[8]
|
Romeo C, Weber MC, Zarei M, et al. HuR contributes to TRAIL resistance by restricting death receptor expression in pancreatic cancer cells[J]. Mol Cancer Res, 2016, 14: 599-611. doi: 10.1158/1541-7786.MCR-15-0448 |
[9]
|
王敏, 彭宣荣, 朱彦丽, 等. HuR VEGF和COX-2表达及临床病理因素与早期宫颈癌患者预后关系的分析[J].中国肿瘤临床, 2010, 37: 984-990. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgzllc201017006 |
[10]
|
胡跃云, 吴宏菊, 辛彦, 等.HuR蛋白在胃癌组织中的表达及其意义[J].中华临床医师杂志, 2011, 5: 91-95. |